Medneon is now a part of Invitae Digital Health. Learn more here.
Our human-centered AI tools empower clinicians to help patients get ahead of life-threatening disease.
Identify cancer risk, eligibility for genetic testing and advanced imaging.
Connect at-risk & newly diagnosed cancer patients to experts.
Genomic & clinical information. Stay updated & share with family.
Interpret test results. Optimize management.
Leading Oncologists, Genetic Counselors & Patient Advocates.
Real-World Evidence (RWE) based on IRB-approved iGAP TM platform.
Decision support accessible to everyone.
Calculate my cancer risk or optimize my treatment.
Understand the risk to my family members.
Determine how to personalize testing, detection and treatment.
Control costs & offer competitive value.
Keep employees healthy.
Get to know the people, thoughts, and the mission behind us.
Identifies an Individual's eligibility for genetic testing
Curates Cancer risk from our AI genetic mutations database
Real-world evidence with an IRB approved IgapTM platform
Our mission is to empower individuals and their care team to get ahead of life-threatening disease. We believe synthesizing and humanizing clinical, imaging, genetic and genomic information will raise provider confidence, optimize interventions, lower health care costs, and save lives.
We're here to illuminate the path.
Leveraging Real-World Evidence (RWE) individually and collectively – combining artificial intelligence and human insights – is the single most impactful step in developing meaningful clinical decision support systems that advance healthcare. That is personalized medicine; that is our goal.
When we identify the risk, we have choices.
Medneon's Predictive Risk Assessment identifies an individual's eligibility for genetic testing and advanced imaging by showing both short-term and lifetime cancer risk.
Request a demo
Interpret results and effectively manage high-risk and newly diagnosed individuals.
Medneon's Personalized Genetic Insights unlocks the most up-to-date AI and human knowledgebase & curates a custom insights report based on an individual's medical history, genetics and genomics results.
Click to see an example Request a demo
Expert second opinions and molecular tumor boards.
Medneon's Patient Review Board allows for deeper discussion and insight into a person's unique risk and cancer profile. Multidisciplinary team interprets evidence and guidelines to develop an actionable, personalized care plan.
Leverage real-world evidence with an IRB approved iGAP™ registry platform.
Medneon's Data Hub collects clinically annotated genomic data, imaging, pathology, treatments, and patient-reported outcomes to advance precision medicine.
CLICK TO SEE HOW OUR DATA MODEL WORKS Request a demo
Share the generational story of risk & disease.
Medneon's My DNA Vault securely stores genomic and clinical information and dynamically updates to enable real-time understanding of risk and precision treatment. With this information captured and formatted to share, we extend the reach of this insight to families and keep people engaged to get ahead of life-threatening disease.
Unlock your vault
Access leading health experts, no matter where you're located.
Medneon's Virtual Care Network connects at-risk and newly diagnosed individuals with our nationwide leading clinical and genetic experts and allows you to find your best care team.
Connect with an expert
When we identify risk, we have choice.
Leverage real-world evidence with an IRB approved registry platform.
The right questions about your personal and family history can determine whether you qualify for genetic testing or supplemental imaging.
Knowing your specific genetic and genomic abnormalities, Medneon's Personalized Genetic Insights will provide you a customized action plan for cancer prevention, early detection and precision therapy.
Talking to the right person about your clinical situation can make all the difference. Powered by our Virtual Care Network of leading oncologists and genetic counselors thru Medneon's Patient Review Board, you can build a personalized expert care team and take your health into your own hands.
Talking to the right person about your genetic history can make all the difference. Medneon's Patient Review Board gives your relatives access to the Virtual Care Network comprised of leading oncologists and genetic counselors to determine your DNA family's cancer risks and proactive steps that can be taken to detect cancer early or prevent it altogether.
Medneon's Predictive Risk Assessment will guide you through curated questions, determine your relative's risk, and if appropriate, provide with the right recommendations for further testing and management.
loved-one-1a
HOW DOES PRA WORK?
Medneon's Predictive Risk Assessment guides you through the important questions about a patient's personal and family history, imaging and other risk factors then calculates eligibility. If recommended, both genetic testing and imaging letters of medical necessity are available for download.
Medneon's Personalized Genetics Insights incorporate ASK2ME™ AI knowledgebase for gene-cancer associations, age adjusted risk curves, NCCN guidelines and expert insights from Medneon clinicians and genetic counselors into a customized management report for providers.
Medneon's Patient Review Board gives your patients access to leading experts for genetic counseling, second opinion consultations, and virtual tumor boards.
Stay updated with the latest mutation-cancer connections from the humanized AI knowledgebase generated from over ten thousand publications.
Use our tool:
Understanding your patients' risk not only reduces short- and long-term healthcare costs but also improves patient satisfaction.
Use our calculator:
Sign up to get free access to tools that identify patients at risk and provide personalized cancer management guidelines. Upon approval, you'll be provided credentials to access the tools.
Identifying cancer before it happens can yield significant opportunity for everyone.
Medneon's Predictive Risk Assessment helps determines an individuals cancer risk based on published models and whether genetic testing or supplemental imaging is medically necessary or meets appropriate use criteria (AUC).
Medneon's Patient Review Board leverages the Virtual Care Networks' multi-disciplinary specialists who can ensure that patients have access to the right testing and therapies for optimal, cost-effective management.
The right test at the right time can yield significant cost savings across populations while improving your beneficiaries' satisfaction.
Did you know that understanding your employees' risk not only reduces short- and long-term healthcare costs but also improves employee engagement?
Medneon's Predictive Risk Assessment allows employees to better understand their risks as well as the steps that can be undertaken to lower risk, stay healthy and improve outcomes.
The Virtual Care Network gives your employees instant access to leading experts from genetic counselors for cancer risk to multi-disciplinary oncologists to personalize management. With the Patient Review Board, you can build an expert care team and take your health into your own hands.
Did you know that understanding your employees' risk not only reduces short-and long-term healthcare costs but also improves employee engagement?
Lorem ipsum dolors
Contact Us